ID   CLAT_HUMAN              Reviewed;         748 AA.
AC   P28329; A2BDF4; A2BDF5; Q16488; Q9BQ23; Q9BQ35; Q9BQE1;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2009, sequence version 4.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=Choline O-acetyltransferase;
DE            Short=CHOACTase;
DE            Short=ChAT;
DE            Short=Choline acetylase;
DE            EC=2.3.1.6;
GN   Name=CHAT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM M), AND VARIANTS GLY-392 AND
RP   MET-461.
RC   TISSUE=Spinal cord;
RX   PubMed=1337937; DOI=10.1016/0169-328X(92)90237-6;
RA   Oda Y., Nakanishi I., Deguchi T.;
RT   "A complementary DNA for human choline acetyltransferase induces two
RT   forms of enzyme with different molecular weights in cultured cells.";
RL   Brain Res. Mol. Brain Res. 16:287-294(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS M; R AND S),
RP   ALTERNATIVE SPLICING, VARIANTS CMS6 PRO-210; ALA-211; THR-305;
RP   CYS-420; LYS-441; GLY-482; LEU-498; LEU-506 AND HIS-560, AND VARIANTS
RP   THR-120; GLY-392 AND MET-461.
RX   PubMed=11172068; DOI=10.1073/pnas.98.4.2017;
RA   Ohno K., Tsujino A., Brengman J.M., Harper C.M., Bajzer Z., Udd B.,
RA   Beyring R., Robb S., Kirkham F.J., Engel A.G.;
RT   "Choline acetyltransferase mutations cause myasthenic syndrome
RT   associated with episodic apnea in humans.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2017-2022(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM R), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 108-748 (ISOFORM M), AND VARIANTS
RP   THR-120 AND MET-461.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 111-669, AND VARIANTS THR-120 AND
RP   MET-461.
RX   PubMed=1388731; DOI=10.1089/dna.1992.11.593;
RA   Lorenzi M.V., Trinidad A.C., Zhang R., Strauss W.L.;
RT   "Two mRNAs are transcribed from the human gene for choline
RT   acetyltransferase.";
RL   DNA Cell Biol. 11:593-603(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 109-232.
RX   PubMed=1339386; DOI=10.1016/0888-7543(92)90395-9;
RA   Toussaint J.L., Geoffroy V., Schmitt M., Werner A., Garnier J.-M.,
RA   Simoni P., Kempf J.;
RT   "Human choline acetyltransferase (CHAT): partial gene sequence and
RT   potential control regions.";
RL   Genomics 12:412-416(1992).
RN   [8]
RP   PROTEIN SEQUENCE OF 161-182; 271-295; 340-352; 376-382; 404-415;
RP   550-559; 572-583; 620-632; 644-648; 650-662 AND 739-748.
RC   TISSUE=Placenta;
RX   PubMed=3183663; DOI=10.1111/j.1471-4159.1988.tb01166.x;
RA   Hersh L.B., Takane K., Gylys K., Moomaw C., Slaughter C.;
RT   "Conservation of amino acid sequences between human and porcine
RT   choline acetyltransferase.";
RL   J. Neurochem. 51:1843-1845(1988).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 688-738.
RC   TISSUE=Lymphocyte;
RX   PubMed=1784419; DOI=10.1016/0304-3940(91)90299-9;
RA   Cervini R., Rocchi M., DiDonato S., Finocchiaro G.;
RT   "Isolation and sub-chromosomal localization of a DNA fragment of the
RT   human choline acetyltransferase gene.";
RL   Neurosci. Lett. 132:191-194(1991).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 120-733 IN COMPLEXES WITH
RP   CHOLINE AND ACETYL COENZYME A.
RX   PubMed=17144655; DOI=10.1021/bi061536l;
RA   Kim A.-R., Rylett R.J., Shilton B.H.;
RT   "Substrate binding and catalytic mechanism of human choline
RT   acetyltransferase.";
RL   Biochemistry 45:14621-14631(2006).
RN   [11]
RP   VARIANT CMS6 THR-336.
RX   PubMed=12756141; DOI=10.1001/archneur.60.5.761;
RA   Kraner S., Laufenberg I., Strassburg H.M., Sieb J.P., Steinlein O.K.;
RT   "Congenital myasthenic syndrome with episodic apnea in patients
RT   homozygous for a CHAT missense mutation.";
RL   Arch. Neurol. 60:761-763(2003).
CC   -!- FUNCTION: Catalyzes the reversible synthesis of acetylcholine
CC       (ACh) from acetyl CoA and choline at cholinergic synapses.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + choline = CoA + O-acetylcholine.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=M; Synonyms=83 kDa;
CC         IsoId=P28329-1; Sequence=Displayed;
CC       Name=S; Synonyms=74 kDa;
CC         IsoId=P28329-2; Sequence=VSP_000790;
CC       Name=R; Synonyms=70 kDa;
CC         IsoId=P28329-3; Sequence=VSP_000791;
CC   -!- DISEASE: Myasthenic syndrome, congenital, 6, presynaptic (CMS6)
CC       [MIM:254210]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness affecting the axial and limb
CC       muscles (with hypotonia in early-onset forms), the ocular muscles
CC       (leading to ptosis and ophthalmoplegia), and the facial and bulbar
CC       musculature (affecting sucking and swallowing, and leading to
CC       dysphonia). The symptoms fluctuate and worsen with physical
CC       effort. CMS6 affected individuals have myasthenic symptoms since
CC       birth or early infancy, negative tests for anti-AChR antibodies,
CC       and abrupt episodic crises with increased weakness, bulbar
CC       paralysis, and apnea precipitated by undue exertion, fever, or
CC       excitement. CMS6 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:11172068, ECO:0000269|PubMed:12756141}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the carnitine/choline acetyltransferase
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Choline acetyltransferase
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Choline_acetyltransferase";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; S56138; AAA14245.1; -; mRNA.
DR   EMBL; AF305907; AAK08953.1; -; mRNA.
DR   EMBL; AF305906; AAK08950.1; -; Genomic_DNA.
DR   EMBL; AF305894; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305895; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305896; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305897; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305898; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305899; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305900; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305901; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305902; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305903; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305904; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305905; AAK08950.1; JOINED; Genomic_DNA.
DR   EMBL; AF305908; AAK08954.1; -; mRNA.
DR   EMBL; AF305906; AAK08951.1; -; Genomic_DNA.
DR   EMBL; AF305894; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305895; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305896; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305897; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305898; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305899; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305900; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305901; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305902; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305903; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305904; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305905; AAK08951.1; JOINED; Genomic_DNA.
DR   EMBL; AF305909; AAK08955.1; -; mRNA.
DR   EMBL; AF305906; AAK08952.1; -; Genomic_DNA.
DR   EMBL; AF305894; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305895; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305896; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305897; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305898; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305899; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305900; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305901; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305902; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305903; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305904; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AF305905; AAK08952.1; JOINED; Genomic_DNA.
DR   EMBL; AC073366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471187; EAW93086.1; -; Genomic_DNA.
DR   EMBL; BC130615; AAI30616.1; -; mRNA.
DR   EMBL; BC130617; AAI30618.1; -; mRNA.
DR   EMBL; S45018; AAB23557.2; -; mRNA.
DR   EMBL; X56585; CAA39923.1; -; Genomic_DNA.
DR   EMBL; X56879; CAA40201.1; -; Genomic_DNA.
DR   CCDS; CCDS44389.1; -. [P28329-2]
DR   CCDS; CCDS7232.1; -. [P28329-1]
DR   CCDS; CCDS7233.1; -. [P28329-3]
DR   PIR; I52631; A60202.
DR   RefSeq; NP_001136401.1; NM_001142929.1.
DR   RefSeq; NP_001136405.1; NM_001142933.1.
DR   RefSeq; NP_001136406.1; NM_001142934.1.
DR   RefSeq; NP_065574.3; NM_020549.4.
DR   RefSeq; NP_066264.3; NM_020984.3.
DR   RefSeq; NP_066265.3; NM_020985.3.
DR   RefSeq; NP_066266.3; NM_020986.3.
DR   UniGene; Hs.302002; -.
DR   PDB; 2FY2; X-ray; 2.25 A; A=120-733.
DR   PDB; 2FY3; X-ray; 2.27 A; A=120-733.
DR   PDB; 2FY4; X-ray; 2.30 A; A=120-733.
DR   PDB; 2FY5; X-ray; 2.60 A; A=120-733.
DR   PDBsum; 2FY2; -.
DR   PDBsum; 2FY3; -.
DR   PDBsum; 2FY4; -.
DR   PDBsum; 2FY5; -.
DR   ProteinModelPortal; P28329; -.
DR   SMR; P28329; -.
DR   BioGrid; 107528; 2.
DR   STRING; 9606.ENSP00000337103; -.
DR   BindingDB; P28329; -.
DR   ChEMBL; CHEMBL4039; -.
DR   DrugBank; DB00122; Choline.
DR   DrugBank; DB00184; Nicotine.
DR   iPTMnet; P28329; -.
DR   PhosphoSitePlus; P28329; -.
DR   BioMuta; CHAT; -.
DR   DMDM; 281185509; -.
DR   PaxDb; P28329; -.
DR   PeptideAtlas; P28329; -.
DR   PRIDE; P28329; -.
DR   DNASU; 1103; -.
DR   Ensembl; ENST00000337653; ENSP00000337103; ENSG00000070748. [P28329-1]
DR   Ensembl; ENST00000339797; ENSP00000343486; ENSG00000070748. [P28329-3]
DR   Ensembl; ENST00000351556; ENSP00000345878; ENSG00000070748. [P28329-3]
DR   Ensembl; ENST00000395559; ENSP00000378926; ENSG00000070748. [P28329-3]
DR   Ensembl; ENST00000395562; ENSP00000378929; ENSG00000070748. [P28329-2]
DR   GeneID; 1103; -.
DR   KEGG; hsa:1103; -.
DR   UCSC; uc001jhv.1; human. [P28329-1]
DR   CTD; 1103; -.
DR   DisGeNET; 1103; -.
DR   GeneCards; CHAT; -.
DR   GeneReviews; CHAT; -.
DR   HGNC; HGNC:1912; CHAT.
DR   HPA; CAB002313; -.
DR   HPA; HPA048547; -.
DR   MalaCards; CHAT; -.
DR   MIM; 118490; gene.
DR   MIM; 254210; phenotype.
DR   neXtProt; NX_P28329; -.
DR   OpenTargets; ENSG00000070748; -.
DR   Orphanet; 98914; Presynaptic congenital myasthenic syndromes.
DR   PharmGKB; PA26448; -.
DR   eggNOG; KOG3717; Eukaryota.
DR   eggNOG; ENOG410XNZ9; LUCA.
DR   GeneTree; ENSGT00760000119220; -.
DR   HOGENOM; HOG000233845; -.
DR   HOVERGEN; HBG107717; -.
DR   InParanoid; P28329; -.
DR   KO; K00623; -.
DR   OMA; MQFVVGR; -.
DR   OrthoDB; EOG091G038F; -.
DR   PhylomeDB; P28329; -.
DR   TreeFam; TF313836; -.
DR   BRENDA; 2.3.1.6; 2681.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   SABIO-RK; P28329; -.
DR   SIGNOR; P28329; -.
DR   EvolutionaryTrace; P28329; -.
DR   GeneWiki; Choline_acetyltransferase; -.
DR   GenomeRNAi; 1103; -.
DR   PRO; PR:P28329; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000070748; -.
DR   CleanEx; HS_CHAT; -.
DR   ExpressionAtlas; P28329; baseline and differential.
DR   Genevisible; P28329; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0004102; F:choline O-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0042136; P:neurotransmitter biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0007269; P:neurotransmitter secretion; TAS:Reactome.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   InterPro; IPR000542; Carn_acyl_trans.
DR   PANTHER; PTHR22589; PTHR22589; 1.
DR   Pfam; PF00755; Carn_acyltransf; 1.
DR   PROSITE; PS00439; ACYLTRANSF_C_1; 1.
DR   PROSITE; PS00440; ACYLTRANSF_C_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing;
KW   Complete proteome; Congenital myasthenic syndrome;
KW   Direct protein sequencing; Disease mutation;
KW   Neurotransmitter biosynthesis; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    748       Choline O-acetyltransferase.
FT                                /FTId=PRO_0000210154.
FT   REGION      520    532       Coenzyme A binding.
FT   ACT_SITE    442    442       Proton acceptor.
FT   BINDING     558    558       Coenzyme A.
FT   BINDING     659    659       Coenzyme A.
FT   MOD_RES     125    125       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P32738}.
FT   MOD_RES     473    473       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P32738}.
FT   VAR_SEQ       1    118       Missing (in isoform R).
FT                                {ECO:0000303|PubMed:11172068,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_000791.
FT   VAR_SEQ       1     95       MGLRTAKKRGLGGGGKWKREEGGGTRGRREVRPACFLQSGG
FT                                RGDPGDVGGPAGNPGCSPHPRAATRPPPLPAHTPAHTPEWC
FT                                GAASAEAAEPRRA -> MWPECRDEALSTV (in
FT                                isoform S).
FT                                {ECO:0000303|PubMed:11172068}.
FT                                /FTId=VSP_000790.
FT   VARIANT      47     47       D -> E (in dbSNP:rs3810948).
FT                                /FTId=VAR_046683.
FT   VARIANT     120    120       A -> T (in dbSNP:rs3810950).
FT                                {ECO:0000269|PubMed:11172068,
FT                                ECO:0000269|PubMed:1388731,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_011675.
FT   VARIANT     210    210       L -> P (in CMS6; impaired activity;
FT                                dbSNP:rs28930071).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011666.
FT   VARIANT     211    211       P -> A (in CMS6; impaired activity;
FT                                dbSNP:rs121912815).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011667.
FT   VARIANT     222    222       R -> P (in dbSNP:rs8178989).
FT                                /FTId=VAR_046684.
FT   VARIANT     243    243       L -> F (in dbSNP:rs8178990).
FT                                /FTId=VAR_046685.
FT   VARIANT     299    299       P -> L (in dbSNP:rs868749).
FT                                /FTId=VAR_046686.
FT   VARIANT     305    305       I -> T (in CMS6; impaired activity;
FT                                dbSNP:rs28929482).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011668.
FT   VARIANT     336    336       I -> T (in CMS6; dbSNP:rs121912823).
FT                                {ECO:0000269|PubMed:12756141}.
FT                                /FTId=VAR_038605.
FT   VARIANT     392    392       A -> G. {ECO:0000269|PubMed:11172068,
FT                                ECO:0000269|PubMed:1337937}.
FT                                /FTId=VAR_011676.
FT   VARIANT     400    400       D -> N (in dbSNP:rs8178991).
FT                                /FTId=VAR_046687.
FT   VARIANT     420    420       R -> C (in CMS6; impaired activity;
FT                                dbSNP:rs121912822).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011669.
FT   VARIANT     441    441       E -> K (in CMS6; completely lack
FT                                activity; dbSNP:rs28930070).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011670.
FT   VARIANT     461    461       V -> M (in dbSNP:rs4838544).
FT                                {ECO:0000269|PubMed:11172068,
FT                                ECO:0000269|PubMed:1337937,
FT                                ECO:0000269|PubMed:1388731,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046688.
FT   VARIANT     482    482       R -> G (in CMS6; impaired activity;
FT                                dbSNP:rs28929481).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011671.
FT   VARIANT     498    498       S -> L (in CMS6; impaired activity;
FT                                dbSNP:rs121912821).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011672.
FT   VARIANT     506    506       V -> L (in CMS6; impaired activity;
FT                                dbSNP:rs121912817).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011673.
FT   VARIANT     560    560       R -> H (in CMS6; impaired activity;
FT                                dbSNP:rs121912819).
FT                                {ECO:0000269|PubMed:11172068}.
FT                                /FTId=VAR_011674.
FT   CONFLICT    151    151       R -> Q (in Ref. 7; CAA39923).
FT                                {ECO:0000305}.
FT   CONFLICT    261    262       GQ -> PE (in Ref. 1; AAA14245).
FT                                {ECO:0000305}.
FT   CONFLICT    396    396       V -> L (in Ref. 6; AAB23557).
FT                                {ECO:0000305}.
FT   CONFLICT    434    434       G -> A (in Ref. 1; AAA14245).
FT                                {ECO:0000305}.
FT   CONFLICT    529    529       C -> S (in Ref. 6; AAB23557).
FT                                {ECO:0000305}.
FT   CONFLICT    567    567       V -> L (in Ref. 6; AAB23557).
FT                                {ECO:0000305}.
FT   CONFLICT    629    630       EL -> DV (in Ref. 6; AAB23557).
FT                                {ECO:0000305}.
FT   CONFLICT    664    664       T -> M (in Ref. 6; AAB23557).
FT                                {ECO:0000305}.
FT   HELIX       139    150       {ECO:0000244|PDB:2FY2}.
FT   HELIX       151    153       {ECO:0000244|PDB:2FY2}.
FT   HELIX       156    169       {ECO:0000244|PDB:2FY2}.
FT   HELIX       175    189       {ECO:0000244|PDB:2FY2}.
FT   STRAND      190    192       {ECO:0000244|PDB:2FY5}.
FT   HELIX       195    202       {ECO:0000244|PDB:2FY2}.
FT   TURN        203    205       {ECO:0000244|PDB:2FY2}.
FT   HELIX       210    213       {ECO:0000244|PDB:2FY2}.
FT   STRAND      217    219       {ECO:0000244|PDB:2FY2}.
FT   HELIX       228    250       {ECO:0000244|PDB:2FY2}.
FT   STRAND      261    263       {ECO:0000244|PDB:2FY4}.
FT   STRAND      265    267       {ECO:0000244|PDB:2FY4}.
FT   HELIX       271    275       {ECO:0000244|PDB:2FY2}.
FT   STRAND      276    282       {ECO:0000244|PDB:2FY2}.
FT   STRAND      285    287       {ECO:0000244|PDB:2FY2}.
FT   STRAND      289    292       {ECO:0000244|PDB:2FY2}.
FT   STRAND      300    308       {ECO:0000244|PDB:2FY2}.
FT   STRAND      311    319       {ECO:0000244|PDB:2FY2}.
FT   HELIX       326    340       {ECO:0000244|PDB:2FY2}.
FT   HELIX       343    345       {ECO:0000244|PDB:2FY2}.
FT   HELIX       350    355       {ECO:0000244|PDB:2FY2}.
FT   HELIX       358    369       {ECO:0000244|PDB:2FY2}.
FT   HELIX       372    382       {ECO:0000244|PDB:2FY2}.
FT   STRAND      387    390       {ECO:0000244|PDB:2FY2}.
FT   HELIX       400    409       {ECO:0000244|PDB:2FY2}.
FT   TURN        413    418       {ECO:0000244|PDB:2FY2}.
FT   STRAND      424    430       {ECO:0000244|PDB:2FY2}.
FT   STRAND      436    440       {ECO:0000244|PDB:2FY2}.
FT   STRAND      442    444       {ECO:0000244|PDB:2FY3}.
FT   HELIX       447    461       {ECO:0000244|PDB:2FY2}.
FT   HELIX       489    508       {ECO:0000244|PDB:2FY2}.
FT   STRAND      509    516       {ECO:0000244|PDB:2FY2}.
FT   HELIX       521    525       {ECO:0000244|PDB:2FY2}.
FT   TURN        526    528       {ECO:0000244|PDB:2FY2}.
FT   HELIX       531    547       {ECO:0000244|PDB:2FY2}.
FT   STRAND      553    558       {ECO:0000244|PDB:2FY2}.
FT   STRAND      567    569       {ECO:0000244|PDB:2FY2}.
FT   HELIX       575    585       {ECO:0000244|PDB:2FY2}.
FT   HELIX       587    589       {ECO:0000244|PDB:2FY2}.
FT   HELIX       593    615       {ECO:0000244|PDB:2FY2}.
FT   HELIX       621    634       {ECO:0000244|PDB:2FY2}.
FT   HELIX       640    643       {ECO:0000244|PDB:2FY2}.
FT   HELIX       645    650       {ECO:0000244|PDB:2FY2}.
FT   STRAND      654    659       {ECO:0000244|PDB:2FY2}.
FT   STRAND      663    665       {ECO:0000244|PDB:2FY2}.
FT   STRAND      667    669       {ECO:0000244|PDB:2FY2}.
FT   STRAND      678    684       {ECO:0000244|PDB:2FY2}.
FT   STRAND      689    696       {ECO:0000244|PDB:2FY2}.
FT   HELIX       704    722       {ECO:0000244|PDB:2FY2}.
SQ   SEQUENCE   748 AA;  82536 MW;  A902364081915391 CRC64;
     MGLRTAKKRG LGGGGKWKRE EGGGTRGRRE VRPACFLQSG GRGDPGDVGG PAGNPGCSPH
     PRAATRPPPL PAHTPAHTPE WCGAASAEAA EPRRAGPHLC IPAPGLTKTP ILEKVPRKMA
     AKTPSSEESG LPKLPVPPLQ QTLATYLQCM RHLVSEEQFR KSQAIVQQFG APGGLGETLQ
     QKLLERQEKT ANWVSEYWLN DMYLNNRLAL PVNSSPAVIF ARQHFPGTDD QLRFAASLIS
     GVLSYKALLD SHSIPTDCAK GQLSGQPLCM KQYYGLFSSY RLPGHTQDTL VAQNSSIMPE
     PEHVIVACCN QFFVLDVVIN FRRLSEGDLF TQLRKIVKMA SNEDERLPPI GLLTSDGRSE
     WAEARTVLVK DSTNRDSLDM IERCICLVCL DAPGGVELSD THRALQLLHG GGYSKNGANR
     WYDKSLQFVV GRDGTCGVVC EHSPFDGIVL VQCTEHLLKH VTQSSRKLIR ADSVSELPAP
     RRLRWKCSPE IQGHLASSAE KLQRIVKNLD FIVYKFDNYG KTFIKKQKCS PDAFIQVALQ
     LAFYRLHRRL VPTYESASIR RFQEGRVDNI RSATPEALAF VRAVTDHKAA VPASEKLLLL
     KDAIRAQTAY TVMAITGMAI DNHLLALREL ARAMCKELPE MFMDETYLMS NRFVLSTSQV
     PTTTEMFCCY GPVVPNGYGA CYNPQPETIL FCISSFHSCK ETSSSKFAKA VEESLIDMRD
     LCSLLPPTES KPLATKEKAT RPSQGHQP
//
